广康生化(300804.SZ):上半年净利润2901.39万元 同比增长32.13%
Group 1 - The core viewpoint of the article is that Guangkang Biochemical (300804.SZ) reported significant growth in its financial performance for the first half of 2025, indicating a strong operational performance [1] Group 2 - The company achieved operating revenue of 399 million yuan, representing a year-on-year increase of 25.55% [1] - The net profit attributable to shareholders of the listed company was 29.01 million yuan, showing a year-on-year growth of 32.13% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 27.48 million yuan, with a remarkable year-on-year increase of 190.00% [1] - The basic earnings per share were reported at 0.3921 yuan [1]